STOCK TITAN

Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Avanos Medical (NYSE: AVNS) has announced its participation in the UBS 2024 Healthcare Conference. Michael Greiner, the company's interim chief executive officer, will engage in a fireside chat on Tuesday, November 12 at approximately 2:45 p.m. Pacific Time. The presentation will be accessible via webcast through the Investors section of the Avanos Medical website, where it will also be archived for future reference.

Avanos Medical (NYSE: AVNS) ha annunciato la sua partecipazione alla UBS 2024 Healthcare Conference. Michael Greiner, l'attuale amministratore delegato ad interim della compagnia, parteciperà a un incontro informale martedì 12 novembre alle 14:45 ora del Pacifico. La presentazione sarà accessibile tramite webcast nella sezione Investitori del sito web di Avanos Medical, dove sarà anche archiviata per future consultazioni.

Avanos Medical (NYSE: AVNS) ha anunciado su participación en la UBS 2024 Healthcare Conference. Michael Greiner, el director ejecutivo interino de la compañía, participará en una charla informal el martes 12 de noviembre a las 2:45 p.m. hora del Pacífico. La presentación estará disponible a través de una transmisión web en la sección de Inversores del sitio web de Avanos Medical, donde también estará archivada para referencia futura.

Avanos Medical (NYSE: AVNS)는 UBS 2024 Healthcare Conference에 참여한다고 발표했습니다. 이 회사의 임시 CEO인 Michael Greiner는 11월 12일 화요일 태평양 표준시 오후 2시 45분에 파이어사이드 채널에 참여할 예정입니다. 발표는 Avanos Medical 웹사이트의 투자자 섹션을 통해 웹캐스트로 확인할 수 있으며, 향후 참고를 위해 아카이브될 것입니다.

Avanos Medical (NYSE: AVNS) a annoncé sa participation à la UBS 2024 Healthcare Conference. Michael Greiner, le directeur général par intérim de l'entreprise, participera à une discussion informelle le mardi 12 novembre à environ 14h45, heure du Pacifique. La présentation sera accessible en streaming via la section Investisseurs du site Web de Avanos Medical, où elle sera également archivée pour une référence future.

Avanos Medical (NYSE: AVNS) hat seine Teilnahme an der UBS 2024 Healthcare Conference bekannt gegeben. Michael Greiner, der interimistische Geschäftsführer des Unternehmens, wird am Dienstag, den 12. November, um ca. 14:45 Uhr pazifischer Zeit an einem Fireside-Chat teilnehmen. Die Präsentation wird über einen Webcast im Bereich Investoren der Avanos Medical Website zugänglich sein, wo sie auch für zukünftige Bezugnahme archiviert wird.

Positive
  • None.
Negative
  • None.

ALPHARETTA, Ga., Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues., Nov. 12 at approximately 2:45 p.m. Pacific Time.

A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical, Inc.

Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit Avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-ubs-healthcare-conference-2024-302300375.html

SOURCE Avanos Medical

FAQ

When is Avanos Medical (AVNS) presenting at the UBS Healthcare Conference 2024?

Avanos Medical (AVNS) will present at the UBS Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m. Pacific Time.

Who will represent Avanos Medical (AVNS) at the UBS Healthcare Conference 2024?

Michael Greiner, interim chief executive officer of Avanos Medical, will represent the company at the UBS Healthcare Conference 2024.

How can investors access Avanos Medical's (AVNS) UBS Healthcare Conference presentation?

Investors can access the presentation via webcast through the Investors section of the Avanos Medical website, where it will also be archived.

What type of presentation will Avanos Medical (AVNS) give at the UBS Healthcare Conference 2024?

Avanos Medical will participate in a fireside chat format presentation at the UBS Healthcare Conference 2024.

Avanos Medical, Inc.

NYSE:AVNS

AVNS Rankings

AVNS Latest News

AVNS Stock Data

938.90M
45.96M
2.95%
94%
1.64%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
ALPHARETTA